Skip to content
Nonprofiteer
← ADVANCED REGENERATIVE MANUFACTURING INSTITUTE INC

Form 990 for tax year 2023

Filed by ADVANCED REGENERATIVE MANUFACTURING INSTITUTE INC.

Totals

Total revenue
$26,819,069
Total expenses
$26,309,774
Contributions and grants received
$24,486,867
Grants paid
$11,333,391
Program service revenue
$2,229,394
Investment income
$102,808
Other revenue
$0
Total assets, end of year
$29,045,430
Total liabilities, end of year
$11,371,178
Net assets or fund balances, end of year
$17,674,252
Program services expenses (Part IX)
not reported
Management and general expenses
not reported
Fundraising expenses
not reported
Program service expenses (Part III)
not reported

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1e · Government grants (contributions)

    $23,981,837

  • 1f · All other contributions, gifts and grants

    $505,030

  • 2a · Program service revenue: Membership Dues

    total $1,076,179 · related or exempt $1,076,179

  • 2b · Program service revenue: Management Fee Revenue

    total $712,874 · related or exempt $712,874

  • 2c · Program service revenue: Other Program Revenue

    total $440,341 · related or exempt $440,341

  • 3 · Investment income

    total $102,808 · excluded $102,808

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $10,702,911

  • 3 · Grants to foreign organizations and individuals

    total $630,480

  • 5 · Compensation of officers, directors and key employees

    total $285,458

  • 7 · Other salaries and wages

    total $5,676,792

  • 8 · Pension plan contributions

    total $131,731

  • 9 · Other employee benefits

    total $489,210

  • 10 · Payroll taxes

    total $443,025

  • 11b · Fees: legal

    total $55,638

  • 11c · Fees: accounting

    total $45,000

  • 11g · Fees: other

    total $1,288,760

  • 12 · Advertising and promotion

    total $29,716

  • 13 · Office expenses

    total $366,339

  • 14 · Information technology

    total $433,756

  • 16 · Occupancy

    total $1,037,269

  • 17 · Travel

    total $176,395

  • 19 · Conferences, conventions and meetings

    total $666,717

  • 22 · Depreciation, depletion and amortization

    total $2,141,641

  • 23 · Insurance

    total $35,646

  • 24a · Other expenses: Lab Materials and Suppl

    total $1,673,290

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $224,206 · end of year $140,238

  • 2 · Savings and temporary cash investments

    beginning of year $9,697,118 · end of year $8,126,955

  • 4 · Accounts receivable

    beginning of year $4,452,276 · end of year $6,802,994

  • 9 · Prepaid expenses and deferred charges

    beginning of year $398,735 · end of year $597,427

  • 10a · Land, buildings and equipment: cost or other basis

    $16,583,628

  • 10b · Land, buildings and equipment: accumulated depreciation

    $5,657,543

  • 10c · Land, buildings and equipment, net

    beginning of year $10,652,869 · end of year $10,926,085

  • 14 · Intangible assets

    beginning of year $119,415 · end of year $76,975

  • 15 · Other assets

    beginning of year $3,105,042 · end of year $2,374,756

  • 17 · Accounts payable and accrued expenses

    beginning of year $6,919,240 · end of year $5,334,402

  • 19 · Deferred revenue

    beginning of year $1,460,422 · end of year $2,204,573

  • 22 · Loans and payables to officers and key people

    end of year $1,457,447

  • 25 · Other liabilities

    beginning of year $3,105,042 · end of year $2,374,756

  • 27 · Net assets without donor restrictions

    beginning of year $17,164,957 · end of year $17,674,252

Mission and programs · 2023

Mission

ARMI's mission is to support, develop, advance and promote the United States bioeconomy.

  • ARMI and its BioFabUSA Institute accomplishes its mission through key activities, such as the following:- Collaborates with community, local, State, and Federal stakeholders to advance the U.S bioeconomy and fuel inclusive economic growth, including by creating pathways and access to jobs in the biofabrication industry. - Provides wrap-around commercialization services for tissue engineering and enabling technology companies. These efforts de-risk and accelerate translation of impactful technologies to market. - Funds technical projects that address many of the common manufacturing challenges faced by companies in the field of tissue engineering. This will allow tissue engineering and enabling technology companies to focus their time and resources on product-specific challenges, moving the entire industry forward more quickly and efficiently. - Funds education and workforce development (EWD) projects that address the industry need for trained employees with a broad base of biomanufacturing skills and specific expertise. This pressing need can otherwise constrain the growth of tissue engineering and enabling technology companies. - In coordination with organizations in the field of regenerative manufacturing, develops roadmaps of technical and EWD needs for the field. These roadmaps guide the work of organizations in the field of regenerative manufacturing and guide the selection of projects. - Hosts, sponsors, and participates in conferences and workshops that convene organizations that support regenerative manufacturing. These events allow for shared learning related to technical, regulatory, workforce, and financial challenges and solutions. - Shares information about best practices and innovations in the field via various fora and online resources.NextFab accomplishes is mission through key activities, such as the following: - Develop commercial advisory and consulting programs designed to accelerate adoption of advanced technologies. - Provide shared facilities to accelerate advanced technologies. - Performs projects of interest to U.S. Department of Health and Human Services.

As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Dean Kamen

    Executive Director

    Total calculated
    $0
    Hours/week
    5
  • Martine Rothblatt

    Board Member

    Total calculated
    $0
    Hours/week
    1
  • John Abele

    Board Member

    Total calculated
    $0
    Hours/week
    1
  • Jim Weinstein

    Board Member

    Total calculated
    $0
    Hours/week
    1
  • Blake Moret

    Board Member

    Total calculated
    $0
    Hours/week
    1
  • Maureen Toohey

    Deputy Executive Director

    Total calculated
    $0
    Hours/week
    15
  • James Scott

    Chief Administrative Officer

    Total calculated
    $0
    Hours/week
    15
  • Brendan Duffy

    Treasurer

    Total calculated
    $0
    Hours/week
    1
  • Jennifer MacDonald

    Chief Operating Officer

    Total calculated
    $285,458
    From this org
    $257,584
    From related orgs
    $0
    Other
    $27,874
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $232,584
    Bonus
    $25,000
    Other
    $0
    Deferred
    $3,269
    Nontaxable benefits
    $24,605
    Filer's total
    $285,458
  • Julie Lenzer

    Chief Innovation Officer

    Total calculated
    $221,038
    From this org
    $196,065
    From related orgs
    $0
    Other
    $24,973
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $196,065
    Bonus
    $0
    Other
    $0
    Deferred
    $8,009
    Nontaxable benefits
    $16,964
    Filer's total
    $221,038
  • Richard McFarland

    Chief Regulatory Officer

    Total calculated
    $222,959
    From this org
    $194,203
    From related orgs
    $0
    Other
    $28,756
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $194,203
    Bonus
    $0
    Other
    $0
    Deferred
    $8,005
    Nontaxable benefits
    $20,751
    Filer's total
    $222,959
  • Edward Gordon

    BioFab Chief Operating Officer

    Total calculated
    $234,883
    From this org
    $191,771
    From related orgs
    $0
    Other
    $43,112
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $191,771
    Bonus
    $0
    Other
    $0
    Deferred
    $8,010
    Nontaxable benefits
    $35,102
    Filer's total
    $234,883
  • Karla Talanian

    Past Chief Workforce Development Officer

    Total calculated
    $174,325
    From this org
    $170,291
    From related orgs
    $0
    Other
    $4,034
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $170,291
    Bonus
    $0
    Other
    $0
    Deferred
    $2,908
    Nontaxable benefits
    $1,126
    Filer's total
    $174,325
  • Michael Orrico

    BioFab Startup Lab Manager

    Total calculated
    $185,005
    From this org
    $166,835
    From related orgs
    $0
    Other
    $18,170
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $166,835
    Bonus
    $0
    Other
    $0
    Deferred
    $2,962
    Nontaxable benefits
    $15,208
    Filer's total
    $185,005

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

None.

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement

The filer's explanations (Part III)

Part I, Line 7
During the calendar year 2023, a one time starting bonus of $25,000 was paid to Jennifer MacDonald and was approved by the Deputy Executive Director.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

The 10 largest by cash amount. The API serves every itemized grant.

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Related corporations and trusts

Part IV: related organizations taxable as a corporation or trust.

  • ARMI Bioindustries Corp

    C · Biotech Manufacturing and Development Services · NH · 100% owned · share of income $778,717 · share of assets $250,486 · controlled entity

    Directly controlled by Advanced Regenerative Manufacturing Institute Inc

Provenance

Return type
form_990
Tax year
2023
Filed
15 November 2024
IRS schema version
2023v5.1
Source object
202423209349318732

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.